Skip NavigationSkip to Content

Poly(ethylene glycol) prodrugs of the CDK inhibitor, alsterpaullone (NSC 705701): Synthesis and pharmacokinetic studies

  1. Author:
    Greenwald, R. B.
    Zhao, H.
    Xia, J.
    Wu, D. C.
    Nervi, S.
    Stinson, S. F.
    Majerova, E.
    Bramhall, C.
    Zaharevitz, D. W.
  2. Author Address

    Enzon Pharmaceut Inc, Div Res & Dev, Piscataway, NJ 08854 USA. NCI, Dev Therapeut Program, Frederick, MD 21702 USA Stinson, SF, Enzon Pharmaceut Inc, Div Res & Dev, 20 Kingsbridge Rd, Piscataway, NJ 08854 USA
    1. Year: 2004
    2. Date: SEP-OCT
  1. Journal: Bioconjugate Chemistry
    1. 15
    2. 5
    3. Pages: 1076-1083
  2. Type of Article: Article
  1. Abstract:

    Two methods were devised to conjugate PEG to alsterpaullone (NSC 705701) via the N of the indole ring portion of the molecule. In the first approach, activation of the indole was accomplished by reaction with p-nitrophenyl chloroformate to produce a reactive carbamate that was then condensed with a mono blocked diamine to form a urea bond followed by deblocking and conjugation to PEG. The second route used the anion of the indole and produced a carbamate bond. Both compounds were highly water soluble, were stable in buffer, and released alsterpaullone in vitro and in vivo. Studies were conducted in mice to investigate the influence of PEGylation on the plasma pharmacokinetics of alsterpaullone. The total plasma clearance rate was decreased up to 32-fold, and the biological halflife lengthened up to 8-fold when alsterpaullone was injected i.v. as a PEG-conjugate and compared to injection of the unconjugated compound. The most pronounced effect on the pharmacokinetics of alsterpaullone was produced by a 40-kDa PEG urea-linked conjugate. When the 40- and 20-kDa urea-linked conjugates were administered by i.p. injection, high relative bioavailability (46% and 99%, respectively) of alsterpaullone was observed

    See More

External Sources

  1. WOS: 000223934300017

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel